MoneyWorks4Me

Parnax Lab reports Profit after tax of Rs 7.27 Mln, in the March 2023 quarter

30 May 2023 Evaluate
Net sales declined -6.97%  to  Rs. 24.43 million from Rs. 26.26 millions.The Profit  for the quarter ended March 2023 of  Rs. 7.27  millions  grew by 68.68% from Rs. 4.31 millions.OP of the company witnessed a marginal growth to 10.58 millions from 8.52 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 24.43 26.26 -6.97 74.74 71.50 4.53 74.74 71.50 4.53
Other Income 1.39 0.66 110.61 3.71 1.62 129.01 3.71 1.62 129.01
PBIDT 10.58 8.52 24.18 19.45 15.29 27.21 19.45 15.29 27.21
Interest 0.32 1.69 -81.07 2.49 7.05 -64.68 2.49 7.05 -64.68
PBDT 10.26 6.83 50.22 16.96 8.24 105.83 16.96 8.24 105.83
Depreciation 0.34 0.14 142.86 0.68 0.45 51.11 0.68 0.45 51.11
PBT 9.92 6.69 48.28 16.28 7.79 108.99 16.28 7.79 108.99
TAX 2.65 2.38 11.34 4.22 2.38 77.31 4.22 2.38 77.31
Deferred Tax 2.65 2.38 11.34 4.22 2.38 77.31 4.22 2.38 77.31
PAT 7.27 4.31 68.68 12.06 5.41 122.92 12.06 5.41 122.92
Equity 114.86 98.15 17.02 114.86 98.15 17.02 114.86 98.15 17.02
PBIDTM(%) 43.31 32.44 33.48 26.02 21.38 21.69 26.02 21.38 21.69
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..